Levin Capital Strategies’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.36M | Buy |
1,495,560
+134,792
| +10% | +$844K | 0.91% | 40 |
|
|
2025
Q1 | $7.97M | Buy |
1,360,768
+113,149
| +9% | +$663K | 0.84% | 45 |
|
|
2024
Q4 | $10.3M | Buy |
1,247,619
+833,984
| +202% | +$6.86M | 0.97% | 38 |
|
|
2024
Q3 | $3.69M | Buy |
413,635
+86,169
| +26% | +$768K | 0.35% | 59 |
|
|
2024
Q2 | $2.48M | Buy |
327,466
+216,266
| +194% | +$1.63M | 0.26% | 59 |
|
|
2024
Q1 | $873K | Buy |
111,200
+11,200
| +11% | +$87.9K | 0.09% | 98 |
|
|
2023
Q4 | $886K | Buy |
100,000
+18,905
| +23% | +$167K | 0.1% | 94 |
|
|
2023
Q3 | $727K | Buy |
81,095
+11,095
| +16% | +$99.5K | 0.09% | 101 |
|
|
2023
Q2 | $865K | Buy |
70,000
+55,000
| +367% | +$679K | 0.1% | 94 |
|
|
2023
Q1 | $139K | Buy |
+15,000
| New | +$139K | 0.02% | 196 |
|